SCHEMBL7428378

SCHEMBL7428378

CC1SC(=O)NN=C1c1ccc2c(c1)C(C)(O)C(=O)N2

nearest known ligand 0.78

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 17/20 0.78
PDE3A Q14432 17/20 0.78
PDE4A P27815 14/20 0.78
PDE4B Q07343 14/20 0.78
PDE4C Q08493 14/20 0.78
PDE4D Q08499 14/20 0.78
FBP1 P09467 1/20 0.39
PGR P06401 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7267795 0.88 PDE3B (1.00) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7431842 0.84 PDE3B (0.75) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7383314 0.83 PDE3B (1.00) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10386700 0.82 PDE3B (0.73) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7432713 0.81 PDE4A (1.00) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7429101 0.81 PDE3B (0.71) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7427262 0.81 PDE4A (1.00) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7438172 0.80 PDE3B (0.69) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7378124 0.80 PDE3B (0.69) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7373436 0.79 PDE3B (0.68) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP claimed
US-4933336-A Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease LABORATOIRES SOBIO S.A. (FR) 1990-06-12 US disclosed
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP disclosed